vitamin k 3 has been researched along with Exanthem in 2 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eriksen, JG | 1 |
| Kaalund, I | 1 |
| Clemmensen, O | 1 |
| Overgaard, J | 1 |
| Pfeiffer, P | 1 |
| Li, T | 1 |
| Perez-Soler, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Placebo-controlled Trial Investigating the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis[NCT01094444] | Phase 2 | 30 participants (Actual) | Interventional | 2010-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for vitamin k 3 and Exanthem
| Article | Year |
|---|---|
Skin toxicities associated with epidermal growth factor receptor inhibitors.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Non-Small-Cell Lung; | 2009 |
1 trial available for vitamin k 3 and Exanthem
| Article | Year |
|---|---|
Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.
Topics: Adult; Aged; Cetuximab; Exanthema; Female; Humans; Male; Middle Aged; Vitamin K 3 | 2017 |